1 completed, 1 unknown. 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Unknown 1 |
| Phase 3 | 1 | Completed 1 |
Follow House Dust Mite Rhinitis: new trials by email Literature Review of House Dust Mite Rhinitis trials Research Report on House Dust Mite Rhinitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Randomized, Double-Blind, Placebo-Controlled, Multi-Centre Study to Assess the Efficacy of PURETHAL Mites Mixture 50,000 AUeq/mL Subcutaneous Immunotherapy in Adult Subjects With Moderate to Severe Allergic Rhinitis/Rhinoconjunctivitis With or Without Asthma Induced by House Dust Mite (HDM) PURETHAL Mites 50,000 AUeq/ml, Biological/Vaccine: Placebo - House Dust Mite Allergy, House Dust Mite Rhinitis | Phase 3 | Completed | HAL Allergy | 691 | 2024-09-09 | 2026-08-10 |
| Comparative Evaluation of Safety and Immune Activity of New Immunotherapeutic Agents for HDM Allergic Rhinitis Patients House Dust Mite Extract, Dermatophagoides Farinae - Mite Allergy, Rhinitis, Allergic | Phase 1 | Unknown | RAPHAS | 54 | 2022-01-20 | 2024-04-10 |
Dust Mite Allergy (1) · Hypersensitivity (1) · Rhinitis (1) · Rhinitis, Allergic (1)
Hypersensitivity, Immediate (2) · Immune System Diseases (2) · Nose Diseases (2) · Otorhinolaryngologic Diseases (2) · Respiratory Hypersensitivity (2) · Respiratory Tract Diseases (2) · Hypersensitivity (1) · Infections (1) · Respiratory Tract Infections (1) · Rhinitis (1) · Rhinitis, Allergic (1) · Rhinitis, Allergic, Perennial (1)
Antigens, Dermatophagoides (1) · Biological Products (1)
HAL Allergy (1) · RAPHAS (1)
Bulgaria (1) · Germany (1) · Latvia (1) · Lithuania (1) · Poland (1) · South Korea (1)
Hans Hoogeveen (1)
2023 (1)